Last update 09 May 2026

Everstar Medicines (Shanghai) Limited

Subsidiary Company|2018|Shanghai Shi, China

Overview

Related

4
Clinical Trials associated with Everstar Medicines (Shanghai) Limited
CTR20201798
/ CompletedPhase 1
一项I期、单中心、开放研究评估Nefecon单次给药在中国健康志愿者中的药代动力学特征及安全性
[Translation] A Phase I, single-center, open-label study to evaluate the pharmacokinetic characteristics and safety of a single dose of Nefecon in healthy Chinese volunteers
NCT04613999
/ CompletedPhase 1
A Phase 1 Open-label, Non-randomized, Single Ascending Dose Escalation Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of A Ralinepag Extended Release (XR) Tablet Formulation In Healthy Chinese Subjects
NCT04176588
/ Unknown statusPhase 3
A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Etrasimod for Induction and Maintenance Treatment in Subjects With Moderately to Severely Active Ulcerative Colitis
100 Clinical Results associated with Everstar Medicines (Shanghai) Limited
Login to view more data
0 Patents (Medical) associated with Everstar Medicines (Shanghai) Limited
Login to view more data
100 Deals associated with Everstar Medicines (Shanghai) Limited
Login to view more data
100 Translational Medicine associated with Everstar Medicines (Shanghai) Limited
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 20 May 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Ralinepag
 ( PGI2 receptor )		Pulmonary Arterial Hypertension
More
Discontinued
Budesonide
 ( GR )		Kidney Failure, Chronic
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free